跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Levecare - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Levecare
Approved
STANDARD
Levecare
Hetero Labs Limited (Unit III)
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
0655b919cc32649f
Company
Hetero Labs Limited (Unit III)
Type
Standard
Approval Details
Approval Id
0655b919cc32649f
Drug Approval Philippines Name
Levecare
Product Name
Levecare
Registration Number
DRP-9033-04
Brand Name
Levecare
Generic Name
Levetiracetam
Dosage Form
Oral Solution
Dosage Strength
100 mg/mL
Manufacturer
Hetero Labs Limited (Unit III)
Importer
Camber Pharmaceuticals, Inc.
Distributor
Multicare Pharmaceuticals Phils. Inc.
Importer Detail Path
/organization/camber-pharmaceuticals-inc
Issuance Date
29 July 2022
Expiry Date
20 August 2025
Pharmacologic Category
Antiepileptic
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
0655b919cc32649f
Type
Standard
Back to Philippines FDA Approvals